or Try an Advanced Search...

    Hepatitis C Virus Infection Stocks List

    Symbol Grade Name % Change
    BMY F Bristol-Myers Squibb Company 0.34
    IONS D Ionis Pharmaceuticals, Inc. -0.60
    RGLS B Regulus Therapeutics Inc. 6.61
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis C Virus Infection stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.86
    MEDX F Horizon Kinetics Medical ETF 5.43
    XPH D SPDR S&P Pharmaceuticals ETF 4.47
    IHE C iShares U.S. Pharmaceutical ETF 4.42
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.31
    View all Hepatitis C Virus Infection ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to XPH Compare MEDX to XPH

        Hepatitis C Virus Infection Stocks Recent News

        Date Stock Title
        Apr 26 BMY Bristol, Sanofi, Takeda gain positive CHMP recommendations
        Apr 26 BMY The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
        Apr 26 BMY CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
        Apr 26 BMY Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
        Apr 26 BMY Q1 2024 Bristol-Myers Squibb Co Earnings Call
        Apr 26 BMY Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
        Apr 25 BMY Bristol Myers Squibb stock tumbles on cost-cutting initiative
        Apr 25 BMY Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
        Apr 25 BMY Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
        Apr 25 BMY Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
        Apr 25 BMY Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
        Apr 25 BMY Bristol-Myer Squibb Company (BMY) Q1 2024 Earnings Call Transcript
        Apr 25 BMY Update: Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall
        Apr 25 BMY Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
        Apr 25 BMY Why Bristol Myers Squibb Stock Is Sinking Today
        Apr 25 BMY Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
        Apr 25 BMY Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
        Apr 25 BMY Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
        Apr 25 BMY Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts
        Apr 25 BMY Is Bristol Myers Squibb Stock a Millionaire Maker?
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis
        Hepatitis C Virus Infection

        Hepatitis C virus (HCV) infection is a contagious liver disease caused by the hepatitis C virus. It is spread through contact with the blood of an infected person. Symptoms of HCV infection can range from mild to severe and may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored stools, joint pain, and jaundice. In some cases, HCV infection can lead to serious liver problems, including cirrhosis and liver cancer. Treatment for HCV infection typically involves a combination of antiviral medications.

        Browse All Tags